West Pharmaceutical Services, a $3.1 billion New York Stock Exchange listed pharmaceutical firm, has announced that it plans to invest €100 million in Waterford and create 150 permanent new jobs in the southeast.
The new facility will produce packaging components for insulin injector cartridges and other high value packaging components, to meet growing demand from its pharmaceutical and biotech customers, many of which are based in Ireland.
Taoiseach Enda Kenny TD said: “I am delighted with this announcement which will create 100 construction jobs during its development and an initial 150 new jobs when operational. It is a massive boost for Waterford and the entire southeast and I am happy that Government was able to assist through the work of the IDA.”
Martin Shanahan, chief executive of IDA Ireland, said: “Ireland has succeeded in attracting over 250 medical device manufacturers employing over 25,000 people in locations across the country. The IDA and its local stakeholders have fought off stiff competition to have this plant located in Ireland. This project is a vote of confidence in the people of Waterford.”
Click here for more on this story.